Reunion’s psychedelic drug headed to late-stage testing
Written by
BioPharma Dive
Published
0
comments
0
min
The drug, which functions similar to psilocybin, scored positive enough results in a mid-stage study that Reunion is now setting up a larger experiment to hopefully secure approval in postpartum depression.